2American Diabetes Association. Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care, 2010, 33:S3.
3Mtiraoui N, Ezzidi I, Turki A, et al. Renin-angiotensin-aldoste- tone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients. J Renin Angiotensin Aldosterone Syst, 2011, 12 : 572-580.
4Kim SM, Chin HJ, Oh YK, et al. Blood pressure-relatecl genes and the progression of IgA nephropathy. Nephron Clin Pratt, 2009,113 : c301-c308.
5Eroglu Z, Cetinkal.p S, Erdogan M, et ah Association of the an- giotensinogen M235T and angiotensin-converting enzyme inser- tion/deletion gene polymorphisms in Turkish type 2 diabetic patients and without nephropathy. J Diabetes Complications, 2008,22 : 186-190.
6Ding W, Wang F, Fang Q, etal. Association between two ge- netic polymorphisms of the renin-angiotensin-aldosterone sys- tem and diabetic nephropathy: a meta-analysis. Mol Biol Rep, 2012,39 : 1293-1303.
7Ahluwalia TS, Ahuja M, Rai TS, et al. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol, 2009,28 : 141-150.
